San Francisco, California, March 04, 2018: Clinical investigations to study the medicinal effect of egg phosphatidylcholine have expanded its potential in treating gallbladder disease, hepatitis, high cholesterol, eczema, premenstrual syndrome (PMS), and in improving the overall functioning of human immune systems. With this, the demand for egg phosphatidylcholine is expected to rise, in turn creating lucrative prospects for the global egg phosphatidylcholine market. A new study by TMR Research, titled “Egg Phosphatidylcholine Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” provides a detailed outlook on the factors enabling growth in the market. The report compiles exhaustive information and relevant statistics sourced via in-depth primary and secondary research. Furthermore, the report highlights various threats that the global egg phosphatidylcholine market is likely to face during the forecast period.
In a recent study, Alberta University’s the Faculty of Agriculture, Life and Environment Sciences demonstrated that the kind of choline consumed – plant or animal-based, is just as essential for proper functioning of immune system in lactating mothers and their babies. Phosphatidylcholine is derived from animal sources such as chicken and egg yolk. In one of the recently conducted studies, a group of rodents was fed phosphatidylcholine to compare immune system maturation in their early postnatal life to another group of rodents who were fed plant-based choline. The study indicated that offspring of both rodents grew at a same rate. However, rodents fed phosphatidylcholine showed greater response. This hints towards that administering phosphatidylcholine has improved the immune system maturation than their plant-based counterparts. Spurred by this factor, the global egg phosphatidylcholine market is likely to witness strong growth trends in the coming years.
Get Sample Copy of this Report @
Besides discussing various factors enabling growth in the global market or those restraining it, the report classifies it in terms of various strategies. Therefore, for the purpose of the study, the report segments the global egg phosphatidylcholine market into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. Among these regions, the market chiefly witnessed high demand in North America and Europe. In addition, Asia Pacific is likely to offer lucrative growth opportunities. Changing food habits of consumers in Asia Pacific and the consequent rise in the demand for supplements to compensate essential nutrient intake in daily diet will boost the egg phosphatidylcholine market in Asia Pacific. Besides these, the rising disposable income, increasing healthcare awareness, and growing availability of egg phosphatidylcholine products are likely to create an environment conducive to the market’s growth in Asia Pacific.
Some of the most prominent companies operating in the global egg phosphatidylcholine market are Kewpie Corporation, NOF America Corporation, Nutrasal Inc, Vitamin Research Products, Jena Bioscience GmbH., Harmony Whole Foods Market, Natural Factors, and Avanti Polar Lipids Inc.